hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine - Melgari, D; Brack, K; Zhang, C; Zhang, Y; El-Harchi, A; Mitcheson, J; Hancox, J (J Am Heart Assoc, 2015)